Metatron Health

Botanical species · safety record

Erythrina variegata

The EFSA Compendium of Botanicals holds 6 constituent measurements for Erythrina variegata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Erythrina variegata L.

6Constituent measurements
0Safety records
4Cited sources
29Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 29 licensed products naming Erythrina variegata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Bark
  • Cortex
  • Stem bark

What the records describe

Constituents measured

  • Alkaloids4
  • Isoflavones1
  • Isoquinoline alkaloids1

Plant parts

  • Bark2
  • Flower1
  • Leaves1
  • Roots and other underground parts1
  • Seed1

Preparations

  • Solvent extraction6

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsSeedSolvent extraction0.11 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
AlkaloidsRoots and other underground partsSolvent extraction0.088 PercentChromatographic testsNo resolvable identifier
AlkaloidsBarkSolvent extraction0.12 PercentChromatographic testsNo resolvable identifier
AlkaloidsLeavesSolvent extraction0.04 PercentChromatographic testsNo resolvable identifier
IsoflavonesBarkSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier
Isoquinoline alkaloidsFlowerSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ghosal, S., Dutta, S. K., Bhattacharya, S. K. Erythrina. Chemical and pharmacological evaluation. II. Alkaloids of Erythrina variegata. Journal of Pharmaceutical Sciences, 1972, p. 1274-1277.
  2. Sharma, SK., Chawla, HM. Structure elucidation of erythrosotidienone and erythromotidienone - Two new isoquinoline alkaloids from Erythrina variegata flowers. JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 1998, vol. 75, no. 10-12, p. 833-837.
  3. Rahman, M.Z., Rahman, M.S., Kaisar, A., Hossain, A., Rashid, M.A. Bioactive isoflavones from erythrina variegata L Erythrina variegata L.'dan Biyoaktif Izoflavonlar . Turkish journal of pharmaceutical sciences, 2010, vol. 7, no. 1, p. 21-28.
  4. SOTOHERNANDEZ, M., JACKSON, AH. ERYTHRINA ALKALOIDS - ISOLATION AND CHARACTERIZATION OF ALKALOIDS FROM 7 ERYTHRINA SPECIES. PLANTA MEDICA, 1994, vol. 60, no. 2, p. 175-177. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature

Europe PMC

Every record indexed for this species, resolvable and re-runnable.

All species

Substance index

Search and browse every species this world holds under source and hash.

Before anything else

Safety Centre

Interactions, contraindications and the escalation boundary this world does not cross.

In its own terms

Traditions

How the living traditions approach preparation, use and context.